Clinical Trial Update: Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of ON101 Cream for chronic diabetic foot ulcers has been terminated. The sponsor is Oneness Biotech …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• ON101 Cream

Snippet

Sponsor: Oneness Biotech Co., Ltd. | Conditions: Chronic Diabetic Foot Ulcers | Phase 3 | Status: TERMINATED